Brian Adams, Chief Legal Officer at Kymera Therapeutics, Inc. (KYMR), sold 6,371 shares at $115.55 ($744K) on 2026-09-04, disclosed to the SEC on 2026-09-04.
Open-market sale of $744k KYMR by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.55 | 1,209 | $140K | 18.8% |
| 2 | $116.81 | 3,025 | $353K | 47.5% |
| 3 | $117.57 | 2,137 | $251K | 33.8% |
| Total | $116.83 avg | 6,371 | $744K | 100% |
| Filing → |
| RLAY | SELL | 2025-03-31 | $846 | — | Filing → |
| RLAY | SELL | 2025-01-30 | $496K | — | Filing → |
| RLAY | SELL | 2024-12-31 | $1K | — | Filing → |